KURA - Kura Oncology Inc. (KURA) CEO Troy Wilson on Q4 2020 Results - Earnings Call Transcript

Kura Oncology, Inc. (KURA) Q4 2020 Results Earnings Conference Call February 24, 2021, 08:00 AM ET Company Participants Pete De Spain - Investor Relations Troy Wilson - President and Chief Executive Officer Marc Grasso - Chief Financial Officer Stephen Dale - Chief Medical Officer Jim Basta - Chief Legal Officer Kirsten Flowers - Chief Commercial Officer Kathy Ford - Chief Operating Officer Conference Call Participants Jonathan Chang - SVB Leerink Brian Marty Auster - Credit Suisse Peter Lawson - Barclays Konstantinos Aprilakis - Stifel Ren Benjamin - JMP Securities Phil Nadeau - Cowen and Company Tyler Van Buren - Piper Sandler Joseph Pantginis - H.C. Wainwright Presentation Operator Ladies and gentlemen, thank you for standing by and welcome to the Kura Oncology Fourth Quarter and Full Year 2020 Earnings Conference Call. At this time, all participant lines are in a listen-only mode. After the speaker presentation, there will be a

For further details see:

Kura Oncology, Inc. (KURA) CEO Troy Wilson on Q4 2020 Results - Earnings Call Transcript